首页> 美国卫生研究院文献>Mediators of Inflammation >Modification of Interleukin-15 Serum Levels in Workers Exposed to Chemotherapeutic Agents
【2h】

Modification of Interleukin-15 Serum Levels in Workers Exposed to Chemotherapeutic Agents

机译:接触以下物质的工人的白细胞介素15血清水平的改变 化学治疗剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytostatic anticancer drugs are known as carcinogenic, mutagenic, and teratogenic risk factors for health care workers occupationally exposed. It has been demonstrated that the administration of interleukin-15 in rat models of colon carcinoma protects against chemotherapy-induced gastrointestinal toxicities. We found that occupational exposure to chemotherapeutic antiblastic agents in vivo modified circulating levels of interleukin-15 in 17 health care workers exposed to antineoplastic drugs in relation to their jobs and in as many healthy age- and sex-matched subjects. Health care workers displayed significantly higher circulating interleukin-15 levels compared to their age-matched controls. If this increase representing an anticancer response remains to be established, these findings strengthen the idea of a therapeutic use of interleukin-15 in the field of cancer.
机译:细胞抑制性抗癌药物被称为职业接触的医护人员的致癌,致突变和致畸危险因素。已经证明在结肠癌的大鼠模型中施用白介素15可防止化学疗法诱导的胃肠道毒性。我们发现,在体内职业暴露于化学治疗性抗药性药物后,暴露于17种接受抗肿瘤药物治疗的医护人员的体内白血球的循环水平与他们的工作以及许多健康的年龄和性别相匹配的受试者有关。与年龄相匹配的对照组相比,医护人员的循环白介素15水平明显更高。如果代表抗癌反应的这种增加仍有待确定,那么这些发现将加强白介素15在癌症领域的治疗用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号